Videos

In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.

A new study makes the case for alternatives to opioids in the treatment of migraine.

Causes of concussion include direct trauma, rapid acceleration-deceleration, and blast injury. Dr. Wilner discusses recent literature.

A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.

Patients underwent one night of a sham stimulation followed by pink noise stimulation delivered during slow wave activity.

An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.

Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.

Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.

Did testosterone treatment improve cognitive function and memory in elderly men diagnosed with low testosterone and age-related memory impairment?

Is selective serotonin reuptake inhibitor use associated with an increased risk of spontaneous intracranial hemorrhage?

Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?

What factors contributed to burnout among your fellow neurologists, and what can you do to reduce your own risk?

Although sauna bathing can be beneficial in cardiovascular disease, how does the practice impact dementia and Alzheimer disease?

Could marijuana use increase the risk of developing Alzheimer disease?

Research in a mouse model identified a source of stem cells in the meninges.

Is loneliness predictive of preclinical Alzheimer disease? Dr. Lazzara discusses a study of cortical amyloid burden and loneliness in older adults.

Dr. Lazzara reports on a study examining the effects of exercise on the cognitive function of older adults with mild cognitive impairment.

Dr. Bobby Lazzara discusses a study examining the validity of close to 400 research papers supporting the effectiveness of brain-training programs.

What is the ideal time frame in which to perform endovascular thrombectomy after large-vessel ischemic stroke?

Dr. Bobby Lazzara reports on a clinical trial of aducanumab, a human monoclonal antibody, in patients with prodromal or mild Alzheimer disease.

What happens when athletes stop training for 10 days? Dr. Lazzara discusses a study of resting cerebral blood flow in gray matter and the hippocampus.

Why is a lower BMI linked to greater dementia risks in the elderly? Dr. Bobby Lazzara discusses a recent analysis using the Harvard Aging Brain Study.

Many stroke patients experience sleep disturbances, but are these disorders risk factors of stroke? Dr. Lazzara reports on a recent study.

In this Medical News Minute, Dr. Bobby Lazzara discusses a study of over 4 million people examining socioeconomic status and risk of brain tumor.

Dr. Bobby Lazzara discusses the first description of reversal of cognitive decline in early Alzheimer disease or its precursors.

In this Medical News Minute, Dr. Bobby Lazzara highlights possible birth defects resulting from women taking pregabalin during pregnancy.

In this Medical News Minute, Dr. Bobby Lazzara discusses a recent finding on Alzheimer disease and chromosome Y in men.

In a proof-of-concept study, 25 patients were exposed to a dose-escalating infusion of SAGE-547 to evaluate the drug’s effect on essential tremor.

Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).

Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.